Loading...

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study of Guanfacine Hydrochloride (SPD503 IR) Administered to Children with Attention Deficit Hyperactivity Disorder (ADHD) - Vivli | NLM Dataset Catalog